ScholarIQanswers from OpenAlex

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

PaperCitations, authors & open-access status

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis have?

ScholarIQcitation count

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis has 103 citations in the OpenAlex counts ScholarIQ stores.

When was Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis published?

ScholarIQyear

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis has 2017 year in the ScholarIQ index.

What is the open-access status of Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis?

ScholarIQoa status

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis has gold oa status in the ScholarIQ index.

What is the DOI of Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis?

ScholarIQdoi

The DOI for Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis is on the source record.

What is the PMID of Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis?

ScholarIQpmid

The PMID for Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis is on the source record.

What is the OpenAlex record for Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis?

ScholarIQopenalex

The OpenAlex for Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial